ArticleBlood cancer discovery2022

Correction: Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.